ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,297.10
-0.21%
US Tech 100
18,078.00
-0.21%
다우존스 지수
39,869.38
-0.10%
Bitcoin
65,354.61
0.17%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Eagle Pharmaceuticals Inc (EGRX)

  7. Eagle Pharmaceuticals Inc (EGRX) 뉴스

EGRX

Eagle Pharmaceuticals (EGRX)

Eagle Pharmaceuticals Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:EGRX
일자시간출처헤드라인심볼기업
2024/05/1522:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
2024/05/1106:27Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:EGRXEagle Pharmaceuticals Inc
2024/03/0906:49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
2024/03/0206:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EGRXEagle Pharmaceuticals Inc
2024/03/0121:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
2024/03/0110:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EGRXEagle Pharmaceuticals Inc
2024/03/0106:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EGRXEagle Pharmaceuticals Inc
2024/02/2922:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
2024/02/1507:09Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:EGRXEagle Pharmaceuticals Inc
2024/02/1405:53Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:EGRXEagle Pharmaceuticals Inc
2024/02/1322:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
2024/02/1303:38Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:EGRXEagle Pharmaceuticals Inc
2024/02/0919:45PR Newswire (US)Eagle Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before February 9, 2024 to Discuss Your Rights - EGRXNASDAQ:EGRXEagle Pharmaceuticals Inc
2024/02/0723:15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:EGRXEagle Pharmaceuticals Inc
2024/02/0707:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EGRXEagle Pharmaceuticals Inc
2024/02/0219:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 9, 2024 - (NASDAQ: EGRX)NASDAQ:EGRXEagle Pharmaceuticals Inc
2024/01/2701:49Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:EGRXEagle Pharmaceuticals Inc
2024/01/2619:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 9, 2024 - (NASDAQ: EGRX)NASDAQ:EGRXEagle Pharmaceuticals Inc
2024/01/1919:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 9, 2024 - (NASDAQ: EGRX)NASDAQ:EGRXEagle Pharmaceuticals Inc
2024/01/1820:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
2024/01/1820:50GlobeNewswire Inc.Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property PortfolioNASDAQ:EGRXEagle Pharmaceuticals Inc
2024/01/1621:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
2024/01/1219:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 9, 2024 - (NASDAQ: EGRX)NASDAQ:EGRXEagle Pharmaceuticals Inc
2024/01/1007:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EGRXEagle Pharmaceuticals Inc
2024/01/1007:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EGRXEagle Pharmaceuticals Inc
2024/01/0519:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 9, 2024 - (NASDAQ: EGRX)NASDAQ:EGRXEagle Pharmaceuticals Inc
2023/12/2309:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EGRXEagle Pharmaceuticals Inc
2023/12/2307:15Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:EGRXEagle Pharmaceuticals Inc
2023/12/2106:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EGRXEagle Pharmaceuticals Inc
2023/12/1819:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 9, 2024 - (NASDAQ: EGRX)NASDAQ:EGRXEagle Pharmaceuticals Inc
 검색 관련기사 보기:NASDAQ:EGRX

최근 히스토리

NYSE
DIS
Walt Disney
NYSE
MCD
McDonalds
NASDAQ
AAPL
Apple
USOTC
ADDYY
Adidas (QX)
NYSE
XOM
Exxon Mobil
CCOM
SILVER
SILVER
USOTC
BNPQY
BNP Paribas (QX)
COIN
ETHUSD
Ethereum
NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
XLE
Energy Select Sector SPDR
USI
USTECH100
US Tech 100
NYSE
AXP
American Express
AMEX
SPY
SPDR S&P 500
AMEX
XLV
Health Care Select Sector
NYSE
MRK
Merck
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유